Generated by Meeveem AI
"Transforming lives through targeted medicines in oncology, rare disease and neuroscience"
Ipsen is a global biopharmaceutical company focused on areas where medical solutions remain scarce. The company develops and commercialises innovative treatments across three therapeutic areas: oncology, rare diseases, and neuroscience. With therapies for neuroendocrine tumors, rare bone disorders, and neurological conditions, Ipsen targets patient populations who face limited options. The company combines global reach with mid-sized agility. Over 5,500 professionals across five continents advance a robust pipeline, forge partnerships with biotechs and academic institutions, and navigate regulatory pathways. Ipsen directs resources where they create the greatest patient impact.
5535
Team Members
1929
Founded
Pharma
Sector
Hybrid
Work Environment
A world where patients living with cancer, rare diseases and neurological conditions have access to transformative medicines that improve and extend their lives.
At Ipsen, our mission is to prolong and improve people's lives and health outcomes and make a positive impact for society.